It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).
This page is not supported in mobiles. Please view it in the desktop version.
BioPharma Solutions offers biologics contract manufacturing using innovative filling line technologies that are specifically designed to protect your biologic's integrity and optimize yield of costly API. This manufacturing process optimization helps meet the needs of biologic molecules with:
With a wealth of experience dealing with biologics, BioPharma Solutions' scientists provide expertise across all areas of parenteral formulation and sterile contract manufacturing:
As the biologics market continues to grow with additional launches, expanding indications, and approval of biosimilars (biologics comprise an estimated ~70% of pipeline), packaging will play a more critical role in differentiating your product. The launch of FLEXBUMIN Albumin (Human) in 2006 introduced Baxter's GALAXY Premix System for use with biologics.
Talk to us at these events